These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6580492)

  • 1. Attempt to prevent doxorubicin-induced acute human myocardial morphologic damage with acetylcysteine.
    Unverferth DV; Jagadeesh JM; Unverferth BJ; Magorien RD; Leier CV; Balcerzak SP
    J Natl Cancer Inst; 1983 Nov; 71(5):917-20. PubMed ID: 6580492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human myocardial morphologic and functional changes in the first 24 hours after doxorubicin administration.
    Unverferth DV; Magorien RD; Unverferth BP; Talley RL; Balcerzak SP; Baba N
    Cancer Treat Rep; 1981; 65(11-12):1093-7. PubMed ID: 7296554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy.
    Torti FM; Bristow MM; Lum BL; Carter SK; Howes AE; Aston DA; Brown BW; Hannigan JF; Meyers FJ; Mitchell EP
    Cancer Res; 1986 Jul; 46(7):3722-7. PubMed ID: 3458531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphologic studies of emdomyocardial biopsy specimens].
    Tószegi A; Krenács L; Högye M; Csanády M; Kertész E; Gaál T; Kovács G
    Morphol Igazsagugyi Orv Sz; 1989 Oct; 29(4):304-9. PubMed ID: 2594028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthracycline cardiomyopathy monitored by morphologic changes.
    Billingham ME; Mason JW; Bristow MR; Daniels JR
    Cancer Treat Rep; 1978 Jun; 62(6):865-72. PubMed ID: 667860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of L-carnitine on adriamycin-induced cardiomyopathy in rabbit.
    Paterna S; Furitano G; Scaffidi L; Barbarino C; Campisi D; Parisi G; Carreca I
    Int J Tissue React; 1984; 6(1):91-5. PubMed ID: 6715123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endomyocardial biopsy as a method of surveilling adriamycin cardiac toxicity. 28 biopsies in 26 patients].
    Bouhour JB; Petitier H; Delajartre AY; Fumoleau P; Rozo L; Nicolas G
    Arch Mal Coeur Vaiss; 1983 Nov; 76(11):1277-83. PubMed ID: 6419695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin.
    Lebrecht D; Kokkori A; Ketelsen UP; Setzer B; Walker UA
    J Pathol; 2005 Dec; 207(4):436-44. PubMed ID: 16278810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early changes in human myocardial nuclei after doxorubicin.
    Unverferth BJ; Magorien RD; Balcerzak SP; Leier CV; Unverferth DV
    Cancer; 1983 Jul; 52(2):215-21. PubMed ID: 6861067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The early changes induced by isoproterenol in the endocardium and adjacent myocardium.
    Noronha-Dutra AA; Steen EM; Woolf N
    Am J Pathol; 1984 Feb; 114(2):231-9. PubMed ID: 6696044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.
    Zhou S; Starkov A; Froberg MK; Leino RL; Wallace KB
    Cancer Res; 2001 Jan; 61(2):771-7. PubMed ID: 11212281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of N-acetylcysteine and selenium against doxorubicin toxicity in rats.
    Park ES; Kim SD; Lee MH; Lee HS; Lee IS; Sung JK; Yoon YS
    J Vet Sci; 2003 Aug; 4(2):129-36. PubMed ID: 14610365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural and histological study of endomyocardial biopsies from patients of dilated cardiomyopathy--a comparative evaluation and their clinical correlation.
    Jindal N; Talwar KK; Chopra P
    Indian Heart J; 1994; 46(6):329-34. PubMed ID: 7797221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.
    Xiang P; Deng HY; Li K; Huang GY; Chen Y; Tu L; Ng PC; Pong NH; Zhao H; Zhang L; Sung RY
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):343-9. PubMed ID: 18379782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thalidomide on isoprenaline-induced acute myocardial injury: a haemodynamic, histopathological and ultrastructural study.
    Loh HK; Sahoo KC; Kishore K; Ray R; Nag TC; Kumari S; Arya DS
    Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):233-9. PubMed ID: 17371527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
    Ramesh N; Pillai RK; Abraham T; Padmaja NP; Hameed S; Vijayaraghavan G
    J Assoc Physicians India; 2006 Jun; 54():449-52. PubMed ID: 16909692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin-induced chronic cardiotoxicity and its protection by liposomal administration.
    Rahman A; More N; Schein PS
    Cancer Res; 1982 May; 42(5):1817-25. PubMed ID: 7066898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute myocarditis. Apropos of a case with an anatomoclinical and ultrastructural study].
    Toussaint M; Duboc D; Weber S; Pfister A; Da Lage C; Degeorges M
    Ann Pathol; 1985; 5(3):209-12. PubMed ID: 4074473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of myocardial cell injury in acute cellular rejection versus acute vascular rejection in cyclosporine-treated heart transplants.
    Hook S; Caple JF; McMahon JT; Myles JL; Ratliff NB
    J Heart Lung Transplant; 1995; 14(2):351-8. PubMed ID: 7779856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.